The production line of IrF6 was unveiled by Head of the Atomic Energy Organization of Iran Mohammad Eslami at the UCF of Isfahan.

Iridium hexafluoride is a compound of iridium and fluorine that is necessary for the isotopic separation of Ir191 and enrichment activities.

IrF6 compound has various applications, such as in brachytherapy -a type of internal radiation therapy where radioactive sources are placed directly into or near the tumor-, low-dose medical radiography, production of radioactive sources utilized in the oil and gas industries, non-destructive testing (NDT), and radiobiology researches.

Iran is now among the few countries with the technical know-how to produce IrF6 and can export the product.